ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 350 filers reported holding ARGENX SE in Q4 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,351,145 | +442.5% | 10,118 | +396.7% | 0.09% | +295.5% |
| Q1 2024 | $802,008 | +35.9% | 2,037 | +69.8% | 0.02% | -4.3% |
| Q3 2023 | $589,956 | -88.8% | 1,200 | -91.5% | 0.02% | -89.5% |
| Q1 2023 | $5,290,636 | +145.7% | 14,200 | +149.8% | 0.22% | +93.0% |
| Q4 2022 | $2,153,270 | +366.1% | 5,684 | +334.2% | 0.11% | +533.3% |
| Q3 2022 | $462,000 | -91.0% | 1,309 | -90.3% | 0.02% | -91.9% |
| Q2 2022 | $5,115,000 | +1726.8% | 13,500 | +1587.5% | 0.22% | +1127.8% |
| Q4 2021 | $280,000 | -71.2% | 800 | -78.4% | 0.02% | -90.8% |
| Q3 2020 | $971,000 | – | 3,700 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 285,198 | $106,259,071 | 29.06% |
| Avoro Capital Advisors LLC | 1,287,500 | $479,696,750 | 7.11% |
| Paradigm Biocapital Advisors LP | 181,172 | $67,501,064 | 6.40% |
| DCF Advisers, LLC | 25,700 | $9,575,310 | 5.86% |
| Artia Global Partners LP | 36,404 | $13,563,402 | 5.01% |
| Bellevue Group AG | 886,928 | $330,451,634 | 4.80% |
| Fairmount Funds Management LLC | 73,526 | $27,394,317 | 4.71% |
| Eagle Health Investments LP | 64,400 | $23,994,152 | 4.67% |
| Decheng Capital Management III (Cayman), LLC | 27,429 | $10,219,497 | 4.12% |
| RTW INVESTMENTS, LP | 482,195 | $179,656,213 | 3.74% |